NFKB1 and inflammatory bowel disease: We identified the MAPK STP as a ‘core’ abnormally active STP in IBD, while NFκB, TGFβ, JAK-STAT1/2, JAK-STAT3, and possibly the Wnt pathway, seem to be differentially involved in the various clinical IBD presentations.